Back

Proteomic biomarkers are linked to QTc interval in patients with chronic heart failure.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - biomarkers 1 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Ms Mylene Barry-Loncq De Jong

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Biomarkers associated with declining cognitive performance in patients hospitalized for acute heart failure
Doctor A. Yaghoubi (Malmoe, SE)
Abstract Slides Video
Presentation thumbnail
Cardiovascular and renal outcomes related to urinary albumin to creatinine ratio in patients with heart failure and reduced ejection fraction: A pooled analysis of ATMOSPHERE and PARADIGM-HF
Doctor L. Shen (Glasgow, CN)
Abstract Slides Video
Presentation thumbnail
Clinical and proteomic profiles of chronic kidney disease in heart failure with preserved and reduced ejection fraction
Mr G. Voordes (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Growth differentiation factor (GDF15) profile and prognostic implications across the left ventricular ejection fraction in chronic heart failure
Doctor K. Teramoto (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Usefulness of CA125 and NT-proBNP for assessing congestion in chronic heart failure. Insights from CARDIOREN registry.
Doctor M. Cobo Marcos (Majadahonda, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - biomarkers 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Plasma proteomics in acute heart failure - a step towards a mechanistic understanding of the disease
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction
thumbnail
Congress Presentation
Circulating metabolites associate with the QT interval in individuals without prevalent cardiovascular disease.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources